[Advances in Experimental Medicine and Biology] GeNeDis 2014 Volume 822 || Toxic Tau Aggregation in ADVlamos, Panayiotis; Alexiou, Athanasios · 2015

[Advances in Experimental Medicine and Biology] GeNeDis 2014 Volume 822 || Individual Severity of AD-Type Lesions, Aß Oligomers, and Comorbidity in the Brain AgingVlamos, Panayiotis; Alexiou, Athanasios · 2015

Glycolytic enzyme inhibitors in cancer treatmentScatena, Roberto; Bottoni, Patrizia; Pontoglio, Alessandro; Mastrototaro, Lucia; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2008

Cancer stem cells: the development of new cancer therapeuticsScatena, Roberto; Bottoni, Patrizia; Pontoglio, Alessandro; Giardina, Bruno · Expert Opinion on Biological Therapy · 2011

An update on pharmacological approaches to neurodegenerative diseasesScatena, Roberto; Martorana, Giuseppe E; Bottoni, Patrizia; Botta, Giorgia; Pastore, Paola; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2007

Mitochondrial Dysfunction by Synthetic Ligands of Peroxisome Proliferator Activated Receptors (PPARs)Roberto Scatena; Giuseppe Martorana; Patrizia Bottoni; Bruno Giardina · 2004

[Advances in Experimental Medicine and Biology] Advances in Mitochondrial Medicine Volume 942 ||Scatena, Roberto; Bottoni, Patrizia; Giardina, Bruno · 2012

Mitochondria, ciglitazone and liver: A neglected interaction in biochemical pharmacologyRoberto Scatena; Patrizia Bottoni; Giuseppe E. Martorana; Federica Vincenzoni; Giorgia Botta; Paola Pastore; Bruno Giardina · 2007

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potentialScatena, Roberto; Bottoni, Patrizia; Martorana, Giuseppe E; Giardina, Bruno · Expert Opinion on Investigational Drugs · 2005

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?Scatena, Roberto; Bottoni, Patrizia; Giardina, Bruno · PPAR Research · 2008